Milestone Scientific (NYSE:MLSS) Receives New Coverage from Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Sunday. The firm set a “hold” rating on the stock.

Milestone Scientific Stock Down 2.1 %

MLSS opened at $0.93 on Friday. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.10. The company has a 50-day simple moving average of $0.97 and a 200 day simple moving average of $0.78. The stock has a market capitalization of $71.82 million, a price-to-earnings ratio of -9.30 and a beta of 1.08.

Milestone Scientific (NYSE:MLSS) last posted its quarterly earnings data on Thursday, August 15th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.01). Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%. The firm had revenue of $1.85 million for the quarter.

Insider Transactions at Milestone Scientific

In related news, Director Leonard Osser sold 141,913 shares of the business’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total transaction of $134,817.35. Following the completion of the transaction, the director now owns 4,602,506 shares in the company, valued at approximately $4,372,380.70. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 24.75% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.